Literature DB >> 9878313

Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats.

S i Seto1, T Kaido, S Yamaoka, A Yoshikawa, S Arii, T Nakamura, M Niwano, M Imamura.   

Abstract

BACKGROUND: Acute endotoxemia is known to cause activation of Kupffer cells as well as serious injury in parenchymal and nonparenchymal cells in the liver. We have recently shown that a continuous recombinant hepatocyte growth factor (rHGF) supply prevents lipopolysaccharide (LPS)-induced liver injury in rats. As an attempt to elucidate the mechanism, here we investigate the cytoprotective effect of rHGF on sinusoidal endothelial cells (SECs) in LPS-induced liver injury in rats.
MATERIALS AND METHODS: In order to supply rHGF continuously to the liver, syngenic rat fibroblasts genetically modified to secret rat rHGF were implanted in the spleen. Fourteen days after cell implantation, we injected LPS intravenously and evaluated SEC damage histologically and blood chemically.
RESULTS: Phosphotungstic acid-hematoxylin staining revealed that rHGF treatment greatly attenuated intrasinusoidal LPS-induced fibrin deposition. The ultrastructural changes in SECs caused by LPS administration in control rats were barely detectable in rHGF-treated rats. Blood chemical analyses showed that rHGF potently suppressed the LPS-induced increase in serum hyaluronic acid and transaminase levels.
CONCLUSIONS: Our results indicate an important role for HGF in SEC protection in vivo and would suggest a novel therapeutic strategy for liver diseases with SEC injury. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878313     DOI: 10.1006/jsre.1998.5472

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Hepatotropic growth factors protect hepatocytes during inflammation by upregulation of antioxidative systems.

Authors:  Matthias Glanemann; Daniel Knobeloch; Sabrina Ehnert; Mihaela Culmes; Claudine Seeliger; Daniel Seehofer; Andreas K Nussler
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.

Authors:  Christophe Corpechot; Veronique Barbu; Dominique Wendum; Nicolas Chignard; Chantal Housset; Raoul Poupon; Olivier Rosmorduc
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin.

Authors:  Rajkumar Cheluvappa; Victoria C Cogger; Sun Young Kwun; Jennifer N O'Reilly; David G Le Couteur; Sarah N Hilmer
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

4.  Antithrombin III injection via the portal vein suppresses liver damage.

Authors:  Masayuki Miyazaki; Masaki Kato; Masatake Tanaka; Kosuke Tanaka; Shinichiro Takao; Motoyuki Kohjima; Tetsuhide Ito; Munechika Enjoji; Makoto Nakamuta; Kazuhiro Kotoh; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

5.  Improvement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

6.  Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression.

Authors:  Hussein Atta; Mahmoud El-Rehany; Olfat Hammam; Hend Abdel-Ghany; Maggie Ramzy; Martin Roderfeld; Elke Roeb; Ayman Al-Hendy; Salama Abdel Raheim; Hatem Allam; Heba Marey
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.